Literature DB >> 16460808

The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Vsevolod V Gurevich1, Eugenia V Gurevich.   

Abstract

The 4 mammalian arrestins serve as almost universal regulators of the largest known family of signaling proteins, G-protein-coupled receptors (GPCRs). Arrestins terminate receptor interactions with G proteins, redirect the signaling to a variety of alternative pathways, and orchestrate receptor internalization and subsequent intracellular trafficking. The elucidation of the structural basis and fine molecular mechanisms of the arrestin-receptor interaction paved the way to the targeted manipulation of this interaction from both sides to produce very stable or extremely transient complexes that helped to understand the regulation of many biologically important processes initiated by active GPCRs. The elucidation of the structural basis of arrestin interactions with numerous non-receptor-binding partners is long overdue. It will allow the construction of fully functional arrestins in which the ability to interact with individual partners is specifically disrupted or enhanced by targeted mutagenesis. These "custom-designed" arrestin mutants will be valuable tools in defining the role of various interactions in the intricate interplay of multiple signaling pathways in the living cell. The identification of arrestin-binding sites for various signaling molecules will also set the stage for designing molecular tools for therapeutic intervention that may prove useful in numerous disorders associated with congenital or acquired disregulation of GPCR signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16460808      PMCID: PMC2562282          DOI: 10.1016/j.pharmthera.2005.09.008

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  266 in total

1.  beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.

Authors:  W E Miller; S Maudsley; S Ahn; K D Khan; L M Luttrell; R J Lefkowitz
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

2.  Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases.

Authors:  A Elorza; S Sarnago; F Mayor
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

3.  Heterologous expression and reconstitution of rhodopsin with rhodopsin kinase and arrestin.

Authors:  S Osawa; D Raman; E R Weiss
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

4.  Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors.

Authors:  R H Oakley; S A Laporte; J A Holt; M G Caron; L S Barak
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

5.  Seven non-contiguous intracellular residues of the lutropin/choriogonadotropin receptor dictate the rate of agonist-induced internalization and its sensitivity to non-visual arrestins.

Authors:  K Nakamura; X Liu; M Ascoli
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

6.  Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization.

Authors:  R H Oakley; S A Laporte; J A Holt; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  1999-11-05       Impact factor: 5.157

7.  Arrestin binding to the M(2) muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop of the receptor.

Authors:  K B Lee; J A Ptasienski; R Pals-Rylaarsdam; V V Gurevich; M M Hosey
Journal:  J Biol Chem       Date:  2000-03-31       Impact factor: 5.157

8.  Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases.

Authors:  J A Pitcher; J J Tesmer; J L Freeman; W D Capel; W C Stone; R J Lefkowitz
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

9.  The ADP ribosylation factor nucleotide exchange factor ARNO promotes beta-arrestin release necessary for luteinizing hormone/choriogonadotropin receptor desensitization.

Authors:  S Mukherjee; V V Gurevich; J C Jones; J E Casanova; S R Frank; E T Maizels; M F Bader; R A Kahn; K Palczewski; K Aktories; M Hunzicker-Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

10.  beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2.

Authors:  K A DeFea; J Zalevsky; M S Thoma; O Déry; R D Mullins; N W Bunnett
Journal:  J Cell Biol       Date:  2000-03-20       Impact factor: 10.539

View more
  230 in total

Review 1.  Synthetic biology with surgical precision: targeted reengineering of signaling proteins.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Cell Signal       Date:  2012-06-01       Impact factor: 4.315

Review 2.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

3.  G-protein betagamma-complex is crucial for efficient signal amplification in vision.

Authors:  Alexander V Kolesnikov; Loryn Rikimaru; Anne K Hennig; Peter D Lukasiewicz; Steven J Fliesler; Victor I Govardovskii; Vladimir J Kefalov; Oleg G Kisselev
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 4.  Mechanisms regulating chemokine receptor activity.

Authors:  Laura D Bennett; James M Fox; Nathalie Signoret
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 5.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

Review 6.  Signal transduction by protease-activated receptors.

Authors:  Unice J K Soh; Michael R Dores; Buxin Chen; JoAnn Trejo
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

Review 7.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 8.  G protein-coupled receptor sorting to endosomes and lysosomes.

Authors:  Adriano Marchese; May M Paing; Brenda R S Temple; JoAnn Trejo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

9.  Molecular mechanism of GPCR-mediated arrestin activation.

Authors:  Naomi R Latorraca; Jason K Wang; Brian Bauer; Raphael J L Townshend; Scott A Hollingsworth; Julia E Olivieri; H Eric Xu; Martha E Sommer; Ron O Dror
Journal:  Nature       Date:  2018-05-02       Impact factor: 49.962

10.  Conformation of receptor-bound visual arrestin.

Authors:  Miyeon Kim; Sergey A Vishnivetskiy; Ned Van Eps; Nathan S Alexander; Whitney M Cleghorn; Xuanzhi Zhan; Susan M Hanson; Takefumi Morizumi; Oliver P Ernst; Jens Meiler; Vsevolod V Gurevich; Wayne L Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.